325.82
price up icon1.91%   6.11
after-market アフターアワーズ: 329.98 4.16 +1.28%
loading
前日終値:
$319.71
開ける:
$322.99
24時間の取引高:
317.00K
Relative Volume:
0.68
時価総額:
$14.70B
収益:
$2.99B
当期純損益:
$1.21B
株価収益率:
13.00
EPS:
25.06
ネットキャッシュフロー:
$1.13B
1週間 パフォーマンス:
+2.19%
1か月 パフォーマンス:
+10.44%
6か月 パフォーマンス:
-11.86%
1年 パフォーマンス:
+17.88%
1日の値動き範囲:
Value
$322.60
$326.30
1週間の範囲:
Value
$315.56
$335.00
52週間の値動き範囲:
Value
$266.98
$417.81

United Therapeutics Corp Stock (UTHR) Company Profile

Name
名前
United Therapeutics Corp
Name
セクター
Healthcare (1171)
Name
電話
(301) 608-9292
Name
住所
1000 SPRING ST, SILVER SPRING, MD
Name
職員
1,305
Name
Twitter
Name
次回の収益日
2024-10-30
Name
最新のSEC提出書
Name
UTHR's Discussions on Twitter

UTHR を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
325.82 14.45B 2.99B 1.21B 1.13B 25.06
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
11.07 50.98B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
170.16 74.41B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
RDHL
Redhill Biopharma Ltd Adr
1.99 4.03M 35.75M 11.57M -26.25M -3.8069
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.96 46.23B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
17.77 20.10B 16.54B -1.64B 749.00M -1.45

United Therapeutics Corp Stock (UTHR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-06-02 開始されました Cantor Fitzgerald Overweight
2025-04-25 ダウングレード Wells Fargo Overweight → Equal Weight
2025-04-21 アップグレード BofA Securities Underperform → Neutral
2024-07-11 ダウングレード Morgan Stanley Overweight → Equal-Weight
2024-02-12 アップグレード Goldman Sell → Neutral
2024-02-05 開始されました Leerink Partners Outperform
2023-12-08 開始されました Wells Fargo Overweight
2022-12-06 開始されました UBS Buy
2022-12-05 開始されました Goldman Sell
2022-10-11 開始されました Morgan Stanley Overweight
2022-09-20 繰り返されました BofA Securities Underperform
2022-09-19 再開されました Wedbush Outperform
2022-02-11 開始されました BTIG Research Neutral
2021-07-14 アップグレード Argus Hold → Buy
2021-04-26 再開されました Credit Suisse Outperform
2021-02-01 アップグレード H.C. Wainwright Neutral → Buy
2020-09-14 再開されました JP Morgan Overweight
2020-06-25 繰り返されました H.C. Wainwright Neutral
2020-03-10 アップグレード Jefferies Hold → Buy
2020-02-27 アップグレード Cowen Market Perform → Outperform
2020-01-31 アップグレード JP Morgan Neutral → Overweight
2019-12-03 開始されました BofA/Merrill Underperform
2019-08-01 アップグレード Jefferies Underperform → Hold
2019-08-01 アップグレード Ladenburg Thalmann Neutral → Buy
2019-07-01 アップグレード Credit Suisse Neutral → Outperform
2019-05-17 アップグレード UBS Sell → Neutral
2019-05-09 アップグレード Credit Suisse Underperform → Neutral
2018-10-12 アップグレード Standpoint Research Hold → Buy
2018-08-08 ダウングレード Credit Suisse Neutral → Underperform
2018-04-03 アップグレード Credit Suisse Underperform → Neutral
2018-02-22 繰り返されました Barclays Underweight
2018-01-18 再開されました Credit Suisse Underperform
2017-12-27 繰り返されました Wedbush Outperform
2017-04-27 繰り返されました Wedbush Outperform
2017-03-30 開始されました UBS Sell
2017-03-16 開始されました Credit Suisse Underperform
すべてを表示

United Therapeutics Corp (UTHR) 最新ニュース

pulisher
Jun 04, 2025

Leerink Partners maintains positive outlook on United Therapeutics stock By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 04, 2025

Leerink Partners maintains positive outlook on United Therapeutics stock - Investing.com

Jun 04, 2025
pulisher
Jun 03, 2025

United Therapeutics (NASDAQ:UTHR) Now Covered by Cantor Fitzgerald - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

United Therapeutics (UTHR) Receives New Overweight Rating from Cantor Fitzgerald | UTHR Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Forecasting The Future: 7 Analyst Projections For United Therapeutics - Benzinga

Jun 02, 2025
pulisher
Jun 02, 2025

United Therapeutics (UTHR) Receives Overweight Rating from Canto - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

United Therapeutics (UTHR) Receives Overweight Rating from Cantor Fitzgerald | UTHR Stock News - GuruFocus

Jun 02, 2025
pulisher
May 29, 2025

Ex-United Therapeutics Exec Can't Dodge IP Suit - Law360

May 29, 2025
pulisher
May 29, 2025

United Therapeutics Co. (NASDAQ:UTHR) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World

May 29, 2025
pulisher
May 29, 2025

Those who invested in United Therapeutics (NASDAQ:UTHR) five years ago are up 151% - Yahoo

May 29, 2025
pulisher
May 27, 2025

Liquidia Scores FDA Nod For Lung Disease Drug Yutrepia, Faces Legal Challenge - Benzinga

May 27, 2025
pulisher
May 27, 2025

Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1 - Yahoo Finance

May 27, 2025
pulisher
May 26, 2025

Eisenmenger Complex Treatment Market 2032: EMA, PDMA, FDA Approvals, Medication, NICE Approvals, Clinical Trials, Revenue, Statistics, Therapies, Prevalence, Companies by DelveInsight - Barchart.com

May 26, 2025
pulisher
May 24, 2025

FDA Approves Liquidia Corporation (LQDA)’s YUTREPIA Amid Patent Dispute - Insider Monkey

May 24, 2025
pulisher
May 24, 2025

Zacks Research Has Pessimistic Outlook of UTHR Q2 Earnings - Defense World

May 24, 2025
pulisher
May 23, 2025

FDA Approves Liquidia's (LQDA) Yutrepia, Court Ruling Pending - GuruFocus

May 23, 2025
pulisher
May 23, 2025

U.S. FDA Approves Liquidia’s YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) - GlobeNewswire Inc.

May 23, 2025
pulisher
May 23, 2025

Zacks Research Issues Negative Estimate for UTHR Earnings - Defense World

May 23, 2025
pulisher
May 21, 2025

HHS layoffs create ‘clear opportunity’ for local health, life sciences companies to add talent - The Business Journals

May 21, 2025
pulisher
May 20, 2025

Liquidia Says UTC Can’t Stop Its New Lung Drug From Launching - Bloomberg Law News

May 20, 2025
pulisher
May 15, 2025

Construction underway for new United Therapeutics facility in Stewartville - KTTC News

May 15, 2025
pulisher
May 14, 2025

Stewartville pig-to-human transplant facility to be complete in 2026 - Post Bulletin

May 14, 2025
pulisher
May 14, 2025

Interesting UTHR Put And Call Options For July 18th - Nasdaq

May 14, 2025
pulisher
May 14, 2025

Q1 Therapeutics Earnings: United Therapeutics (NASDAQ:UTHR) Impresses - Yahoo Finance

May 14, 2025
pulisher
May 13, 2025

UTHR Q1 Earnings Call: Double-Digit Growth Continues, Pipeline Expansion Remains Central - Yahoo Finance

May 13, 2025
pulisher
May 12, 2025

UTC Again Seeks To Stave Off Lung Drug Competitor In IP Suit - Law360

May 12, 2025
pulisher
May 12, 2025

Liquidia Faces Patent Litigation Filed by United Therapeutics - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

Liquidia (LQDA) Faces Patent Infringement Lawsuit from United Th - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Liquidia Says New Litigation Filed Against Co In U.S. - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics - Yahoo Finance

May 12, 2025
pulisher
May 11, 2025

Is United Therapeutics (UTHR) the Best Stock to Buy According to Jim Simons’ Renaissance Technologies? - Insider Monkey

May 11, 2025
pulisher
May 09, 2025

Liquidia Corp (LQDA) Q1 2025 Earnings Call Highlights: Strategic Advances and Legal Wins Propel ... - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

3 Big Reasons to Love United Therapeutics (UTHR) - Yahoo Finance

May 09, 2025
pulisher
May 08, 2025

MANNKIND CORP SEC 10-Q Report - TradingView

May 08, 2025
pulisher
May 08, 2025

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update - Yahoo Finance

May 08, 2025
pulisher
May 07, 2025

TD Cowen maintains United Therapeutics stock Buy rating By Investing.com - Investing.com Nigeria

May 07, 2025
pulisher
May 07, 2025

TD Cowen maintains United Therapeutics stock Buy rating - Investing.com

May 07, 2025
pulisher
May 07, 2025

3 Market-Beating Stocks with Solid Fundamentals - Yahoo Finance

May 07, 2025
pulisher
May 06, 2025

United Therapeutics (UTHR) Target Price Lowered by Argus, Retains Buy Rating | UTHR Stock News - GuruFocus

May 06, 2025
pulisher
May 05, 2025

Liquidia Fends Off Indication Challenge In UTC Tyvaso Fight - Law360

May 05, 2025
pulisher
May 05, 2025

United Therapeutics (UTHR) Receives Reiterated "Buy" Rating from HC Wainwright | UTHR Stock News - GuruFocus

May 05, 2025
pulisher
May 02, 2025

US judge dismisses United Therapeutics' counterclaims over Liquidia's 'Yutrepia' - MLex

May 02, 2025
pulisher
May 02, 2025

United Therapeutics (UTHR) Gets a Hold from Wells Fargo - The Globe and Mail

May 02, 2025
pulisher
May 02, 2025

Legal Victory: Liquidia Clears Major Hurdle for YUTREPIA Dual-Indication Approval This Month - Stock Titan

May 02, 2025
pulisher
May 01, 2025

BofA raises United Therapeutics stock target to $321 - Investing.com Australia

May 01, 2025
pulisher
May 01, 2025

United Therapeutics (UTHR): Morgan Stanley Raises Price Target | - GuruFocus

May 01, 2025
pulisher
May 01, 2025

BofA raises United Therapeutics stock target to $321 By Investing.com - Investing.com Canada

May 01, 2025
pulisher
May 01, 2025

United Therapeutics (UTHR) Analyst Update: JP Morgan Maintains R - GuruFocus

May 01, 2025
pulisher
May 01, 2025

United Therapeutics (UTHR) Analyst Update: JP Morgan Maintains Rating | UTHR Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

United Therapeutics (UTHR): Morgan Stanley Raises Price Target | UTHR Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Decoding United Therapeutics Corp (UTHR): A Strategic SWOT Insig - GuruFocus

May 01, 2025

United Therapeutics Corp (UTHR) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

United Therapeutics Corp (UTHR) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
EDGEMOND JAMES
CFO AND TREASURER
Jun 02 '25
Sale
325.82
12,000
3,909,893
8,118
drug_manufacturers_specialty_generic HCM
$15.35
price up icon 0.59%
drug_manufacturers_specialty_generic RDY
$15.55
price up icon 0.13%
$125.39
price up icon 0.63%
$8.71
price up icon 2.96%
$17.77
price up icon 3.01%
大文字化:     |  ボリューム (24 時間):